Dow Jones

44 820,26

-0,20%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Canadá
TSXV
Kane Biotech Inc (KNE)
Kane Biotech Inc (KNE) Actualités

KNE

Kane Biotech (KNE)

Kane Biotech Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:TSXV:KNE

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
12/11/2024	19h32	PR Newswire (Canada)	L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - KNE	TSXV:KNE	Kane Biotech Inc
12/11/2024	19h27	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trade Resumption - KNE	TSXV:KNE	Kane Biotech Inc
12/11/2024	19h05	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - KNE	TSXV:KNE	Kane Biotech Inc
12/11/2024	19h01	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - KNE	TSXV:KNE	Kane Biotech Inc
15/04/2024	17h07	AllPennyStocks.com	Dual Listed Biotech Firm Achieves Sale of Animal Health Interest, Sending Shares Higher	TSXV:KNE	Kane Biotech Inc
25/05/2023	16h51	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - KNE	TSXV:KNE	Kane Biotech Inc
25/05/2023	16h48	PR Newswire (Canada)	IIROC Trading Resumption - KNE	TSXV:KNE	Kane Biotech Inc
25/05/2023	14h59	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - KNE	TSXV:KNE	Kane Biotech Inc
25/05/2023	14h57	PR Newswire (Canada)	IIROC Trading Halt - KNE	TSXV:KNE	Kane Biotech Inc
18/06/2020	20h36	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation sur la Bourse de croissance TSX - KNE	TSXV:KNE	Kane Biotech Inc
18/06/2020	20h34	PR Newswire (Canada)	IIROC TSXV Business Resumption - KNE	TSXV:KNE	Kane Biotech Inc
22/07/2014	14h30	Marketwired Canada	Health Canada Approves DispersinB(R) for Human Use	TSXV:KNE	Kane Biotech Inc
26/06/2014	16h39	Marketwired Canada	Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest	TSXV:KNE	Kane Biotech Inc
18/06/2014	17h24	Marketwired	Kane Biotech Announces Grant of Options	TSXV:KNE	Kane Biotech Inc
05/06/2014	17h42	Marketwired	Kane Biotech Announces Board Members	TSXV:KNE	Kane Biotech Inc
08/04/2014	13h46	Marketwired Canada	Quinsam Monthly Update for March 2014	TSXV:KNE	Kane Biotech Inc
02/04/2014	17h12	Marketwired	Kane Biotech Appoints Dr. Sarah Prichard, M.D. to the Board of Directors	TSXV:KNE	Kane Biotech Inc
26/03/2014	15h30	Marketwired	StrixNB(TM) Powder Formulation Approved by Health Canada's LRVHP Program	TSXV:KNE	Kane Biotech Inc
11/03/2014	13h00	Marketwired Canada	StrixNB(TM) Effective Against Cat Bite Wound Infections	TSXV:KNE	Kane Biotech Inc
04/02/2014	14h00	Marketwired	Kane Biotech Receives $397,500 From Warrant Exercise	TSXV:KNE	Kane Biotech Inc
07/01/2014	14h00	Marketwired	DispersinB(R) Topical Spray Approval from Health Canada's LRVHP Program	TSXV:KNE	Kane Biotech Inc
18/12/2013	23h57	Marketwired	Kane Biotech Announces Closing of Private Placement Offering	TSXV:KNE	Kane Biotech Inc
17/12/2013	14h00	Marketwired	Kane Biotech Signs Option Agreement With Global Health Care Company	TSXV:KNE	Kane Biotech Inc
06/12/2013	14h00	Marketwired	Kane Biotech Announces Extension of Warrants and Private Placement Offering	TSXV:KNE	Kane Biotech Inc
06/11/2013	13h00	Marketwired Canada	New StrixNB(TM) Pet Oral Care Approval from Heath Canada's LRVHP Program	TSXV:KNE	Kane Biotech Inc
22/05/2013	13h00	Marketwired Canada	BC Pet Owners Have a New Weapon Against Dog Breath	TSXV:KNE	Kane Biotech Inc
04/04/2013	14h00	Marketwired Canada	StrixNB(TM) Significantly Reduces Bad Breath in Dogs	TSXV:KNE	Kane Biotech Inc
03/04/2013	14h00	Marketwired Canada	DispersinB(R) Combination Wound Care Product Passes Skin Irritation Tests	TSXV:KNE	Kane Biotech Inc
18/03/2013	13h00	Marketwired Canada	Kane Biotech Appoints Distribution Partner for StrixNB(TM) Western Canada Launch	TSXV:KNE	Kane Biotech Inc
21/02/2013	13h00	Marketwired Canada	Kane Biotech Reports Successful Launch of StrixNB(TM)	TSXV:KNE	Kane Biotech Inc